BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8972241)

  • 1. Selective inhibitors of cyclooxygenase-2. Potential in elderly patients.
    Davies NM; Wallace JL
    Drugs Aging; 1996 Dec; 9(6):406-17. PubMed ID: 8972241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
    Pascucci RA
    J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly.
    Bell GM; Schnitzer TJ
    Clin Geriatr Med; 2001 Aug; 17(3):489-502, vi. PubMed ID: 11459717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials.
    Hawk ET; Viner JL; Umar A
    Prog Exp Tumor Res; 2003; 37():210-42. PubMed ID: 12795057
    [No Abstract]   [Full Text] [Related]  

  • 5. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
    Feldman M; McMahon AT
    Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
    Wigand R
    Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA; Dubois RN
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs to prevent colorectal cancer: a question of sensitivity.
    Elder DJ; Paraskeva C
    Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New nonsteroidal antirheumatic drugs].
    Forster A; Michel BA
    Praxis (Bern 1994); 2000 May; 89(20):855-60. PubMed ID: 10865508
    [No Abstract]   [Full Text] [Related]  

  • 16. Intelligent use of NSAIDs--where do we stand?
    Berger RG
    Expert Opin Pharmacother; 2001 Jan; 2(1):19-30. PubMed ID: 11336565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New anti-inflammatory analgetics--are they needed?].
    Paakkari I
    Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclooxygenase-2 as a target for prevention of colorectal cancer.
    Bertagnolli MM
    Curr Oncol Rep; 1999; 1(2):173-8. PubMed ID: 11122816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.